Report Detail

Request for Sample of this report

Medical Devices & Consumables Global Prescription Digital Therapeutic Market 2023 by Company, Regions, Type and Application, Forecast to 2029

  • RnM4515846
    • |
  • 22 February, 2023
    • |
  • Global
    • |
  • 113 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Prescription Digital Therapeutic market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Prescription Digital Therapeutic market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Prescription Digital Therapeutic market size and forecasts, in consumption value ($ Million), 2018-2029
Global Prescription Digital Therapeutic market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Prescription Digital Therapeutic market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Prescription Digital Therapeutic market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Prescription Digital Therapeutic
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Prescription Digital Therapeutic market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Better Therapeutics, BigHealth, Biofourmis, Click Therapeutics and Happify, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Prescription Digital Therapeutic market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Outpatient Treatment
Monotherapy
Market segment by Application
Hospitals
Specialty Clinics
Others
Market segment by players, this report covers
Better Therapeutics
BigHealth
Biofourmis
Click Therapeutics
Happify
Limbix Health
Medtronic
NuvoAir AB
Omada Health
Pear Therapeutics
ResMed
SAMSUNGHEALTHCARE
Sensyne Health
Solera Network
Voluntis
Welldoc’s Bluestar
Xealth
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Prescription Digital Therapeutic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Prescription Digital Therapeutic, with revenue, gross margin and global market share of Prescription Digital Therapeutic from 2018 to 2023.
Chapter 3, the Prescription Digital Therapeutic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Prescription Digital Therapeutic market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Prescription Digital Therapeutic.
Chapter 13, to describe Prescription Digital Therapeutic research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Prescription Digital Therapeutic
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Prescription Digital Therapeutic by Type
    • 1.3.1 Overview: Global Prescription Digital Therapeutic Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Prescription Digital Therapeutic Consumption Value Market Share by Type in 2022
    • 1.3.3 Outpatient Treatment
    • 1.3.4 Monotherapy
  • 1.4 Global Prescription Digital Therapeutic Market by Application
    • 1.4.1 Overview: Global Prescription Digital Therapeutic Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospitals
    • 1.4.3 Specialty Clinics
    • 1.4.4 Others
  • 1.5 Global Prescription Digital Therapeutic Market Size & Forecast
  • 1.6 Global Prescription Digital Therapeutic Market Size and Forecast by Region
    • 1.6.1 Global Prescription Digital Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Prescription Digital Therapeutic Market Size by Region, (2018-2029)
    • 1.6.3 North America Prescription Digital Therapeutic Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Prescription Digital Therapeutic Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Prescription Digital Therapeutic Market Size and Prospect (2018-2029)
    • 1.6.6 South America Prescription Digital Therapeutic Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Prescription Digital Therapeutic Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 Better Therapeutics
    • 2.1.1 Better Therapeutics Details
    • 2.1.2 Better Therapeutics Major Business
    • 2.1.3 Better Therapeutics Prescription Digital Therapeutic Product and Solutions
    • 2.1.4 Better Therapeutics Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Better Therapeutics Recent Developments and Future Plans
  • 2.2 BigHealth
    • 2.2.1 BigHealth Details
    • 2.2.2 BigHealth Major Business
    • 2.2.3 BigHealth Prescription Digital Therapeutic Product and Solutions
    • 2.2.4 BigHealth Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 BigHealth Recent Developments and Future Plans
  • 2.3 Biofourmis
    • 2.3.1 Biofourmis Details
    • 2.3.2 Biofourmis Major Business
    • 2.3.3 Biofourmis Prescription Digital Therapeutic Product and Solutions
    • 2.3.4 Biofourmis Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Biofourmis Recent Developments and Future Plans
  • 2.4 Click Therapeutics
    • 2.4.1 Click Therapeutics Details
    • 2.4.2 Click Therapeutics Major Business
    • 2.4.3 Click Therapeutics Prescription Digital Therapeutic Product and Solutions
    • 2.4.4 Click Therapeutics Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Click Therapeutics Recent Developments and Future Plans
  • 2.5 Happify
    • 2.5.1 Happify Details
    • 2.5.2 Happify Major Business
    • 2.5.3 Happify Prescription Digital Therapeutic Product and Solutions
    • 2.5.4 Happify Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Happify Recent Developments and Future Plans
  • 2.6 Limbix Health
    • 2.6.1 Limbix Health Details
    • 2.6.2 Limbix Health Major Business
    • 2.6.3 Limbix Health Prescription Digital Therapeutic Product and Solutions
    • 2.6.4 Limbix Health Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Limbix Health Recent Developments and Future Plans
  • 2.7 Medtronic
    • 2.7.1 Medtronic Details
    • 2.7.2 Medtronic Major Business
    • 2.7.3 Medtronic Prescription Digital Therapeutic Product and Solutions
    • 2.7.4 Medtronic Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Medtronic Recent Developments and Future Plans
  • 2.8 NuvoAir AB
    • 2.8.1 NuvoAir AB Details
    • 2.8.2 NuvoAir AB Major Business
    • 2.8.3 NuvoAir AB Prescription Digital Therapeutic Product and Solutions
    • 2.8.4 NuvoAir AB Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 NuvoAir AB Recent Developments and Future Plans
  • 2.9 Omada Health
    • 2.9.1 Omada Health Details
    • 2.9.2 Omada Health Major Business
    • 2.9.3 Omada Health Prescription Digital Therapeutic Product and Solutions
    • 2.9.4 Omada Health Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Omada Health Recent Developments and Future Plans
  • 2.10 Pear Therapeutics
    • 2.10.1 Pear Therapeutics Details
    • 2.10.2 Pear Therapeutics Major Business
    • 2.10.3 Pear Therapeutics Prescription Digital Therapeutic Product and Solutions
    • 2.10.4 Pear Therapeutics Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Pear Therapeutics Recent Developments and Future Plans
  • 2.11 ResMed
    • 2.11.1 ResMed Details
    • 2.11.2 ResMed Major Business
    • 2.11.3 ResMed Prescription Digital Therapeutic Product and Solutions
    • 2.11.4 ResMed Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 ResMed Recent Developments and Future Plans
  • 2.12 SAMSUNGHEALTHCARE
    • 2.12.1 SAMSUNGHEALTHCARE Details
    • 2.12.2 SAMSUNGHEALTHCARE Major Business
    • 2.12.3 SAMSUNGHEALTHCARE Prescription Digital Therapeutic Product and Solutions
    • 2.12.4 SAMSUNGHEALTHCARE Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 SAMSUNGHEALTHCARE Recent Developments and Future Plans
  • 2.13 Sensyne Health
    • 2.13.1 Sensyne Health Details
    • 2.13.2 Sensyne Health Major Business
    • 2.13.3 Sensyne Health Prescription Digital Therapeutic Product and Solutions
    • 2.13.4 Sensyne Health Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Sensyne Health Recent Developments and Future Plans
  • 2.14 Solera Network
    • 2.14.1 Solera Network Details
    • 2.14.2 Solera Network Major Business
    • 2.14.3 Solera Network Prescription Digital Therapeutic Product and Solutions
    • 2.14.4 Solera Network Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Solera Network Recent Developments and Future Plans
  • 2.15 Voluntis
    • 2.15.1 Voluntis Details
    • 2.15.2 Voluntis Major Business
    • 2.15.3 Voluntis Prescription Digital Therapeutic Product and Solutions
    • 2.15.4 Voluntis Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Voluntis Recent Developments and Future Plans
  • 2.16 Welldoc’s Bluestar
    • 2.16.1 Welldoc’s Bluestar Details
    • 2.16.2 Welldoc’s Bluestar Major Business
    • 2.16.3 Welldoc’s Bluestar Prescription Digital Therapeutic Product and Solutions
    • 2.16.4 Welldoc’s Bluestar Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Welldoc’s Bluestar Recent Developments and Future Plans
  • 2.17 Xealth
    • 2.17.1 Xealth Details
    • 2.17.2 Xealth Major Business
    • 2.17.3 Xealth Prescription Digital Therapeutic Product and Solutions
    • 2.17.4 Xealth Prescription Digital Therapeutic Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Xealth Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Prescription Digital Therapeutic Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Prescription Digital Therapeutic by Company Revenue
    • 3.2.2 Top 3 Prescription Digital Therapeutic Players Market Share in 2022
    • 3.2.3 Top 6 Prescription Digital Therapeutic Players Market Share in 2022
  • 3.3 Prescription Digital Therapeutic Market: Overall Company Footprint Analysis
    • 3.3.1 Prescription Digital Therapeutic Market: Region Footprint
    • 3.3.2 Prescription Digital Therapeutic Market: Company Product Type Footprint
    • 3.3.3 Prescription Digital Therapeutic Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Prescription Digital Therapeutic Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Prescription Digital Therapeutic Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Prescription Digital Therapeutic Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Prescription Digital Therapeutic Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Prescription Digital Therapeutic Consumption Value by Type (2018-2029)
  • 6.2 North America Prescription Digital Therapeutic Consumption Value by Application (2018-2029)
  • 6.3 North America Prescription Digital Therapeutic Market Size by Country
    • 6.3.1 North America Prescription Digital Therapeutic Consumption Value by Country (2018-2029)
    • 6.3.2 United States Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Prescription Digital Therapeutic Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Prescription Digital Therapeutic Consumption Value by Type (2018-2029)
  • 7.2 Europe Prescription Digital Therapeutic Consumption Value by Application (2018-2029)
  • 7.3 Europe Prescription Digital Therapeutic Market Size by Country
    • 7.3.1 Europe Prescription Digital Therapeutic Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
    • 7.3.3 France Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Prescription Digital Therapeutic Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Prescription Digital Therapeutic Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Prescription Digital Therapeutic Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Prescription Digital Therapeutic Market Size by Region
    • 8.3.1 Asia-Pacific Prescription Digital Therapeutic Consumption Value by Region (2018-2029)
    • 8.3.2 China Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
    • 8.3.5 India Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Prescription Digital Therapeutic Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Prescription Digital Therapeutic Consumption Value by Type (2018-2029)
  • 9.2 South America Prescription Digital Therapeutic Consumption Value by Application (2018-2029)
  • 9.3 South America Prescription Digital Therapeutic Market Size by Country
    • 9.3.1 South America Prescription Digital Therapeutic Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Prescription Digital Therapeutic Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Prescription Digital Therapeutic Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Prescription Digital Therapeutic Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Prescription Digital Therapeutic Market Size by Country
    • 10.3.1 Middle East & Africa Prescription Digital Therapeutic Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Prescription Digital Therapeutic Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Prescription Digital Therapeutic Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Prescription Digital Therapeutic Market Drivers
  • 11.2 Prescription Digital Therapeutic Market Restraints
  • 11.3 Prescription Digital Therapeutic Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Prescription Digital Therapeutic Industry Chain
  • 12.2 Prescription Digital Therapeutic Upstream Analysis
  • 12.3 Prescription Digital Therapeutic Midstream Analysis
  • 12.4 Prescription Digital Therapeutic Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Prescription Digital Therapeutic. Industry analysis & Market Report on Prescription Digital Therapeutic is a syndicated market report, published as Global Prescription Digital Therapeutic Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Prescription Digital Therapeutic market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,777.04
    		4,165.56
    		5,554.08
    		3,246.84
    		4,870.26
    		6,493.68
    		535,084.80
    		802,627.20
    		1,070,169.60
    		290,440.80
    		435,661.20
    		580,881.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo